Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 7/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9729223 | 0.85 | TACR1 (0.56) | TACR1TSHRMEN1CYP3A4MAPT | |
| SCHEMBL9730197 | 0.85 | TACR1 (0.53) | TACR1TSHRMEN1CYP3A4MAPT | |
| SCHEMBL9730495 | 0.84 | TACR1 (0.55) | TACR1TSHRMEN1CYP3A4MAPT | |
| SCHEMBL9730151 | 0.83 | TACR1 (0.52) | TACR1TSHRMEN1CYP3A4MAPT | |
| Iodide SCHEMBL9729835 | 0.82 | TACR1 (0.52) | TACR1TSHRMEN1CYP3A4MAPT | |
| SCHEMBL9729350 | 0.82 | TACR1 (0.53) | TACR1TSHRMEN1CYP3A4MAPT | |
| SCHEMBL9729555 | 0.81 | TACR1 (0.50) | TACR1TSHRMEN1CYP3A4MAPT | |
| SCHEMBL9729441 | 0.81 | TACR1 (0.52) | TACR1TSHRMEN1CYP3A4MAPT | |
| SCHEMBL9730595 | 0.81 | TACR1 (0.58) | TACR1TSHRMEN1CYP3A4MAPT | |
| SCHEMBL9729849 | 0.81 | TACR1 (0.58) | TACR1TSHRMEN1CYP3A4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5102667-A | Antiallergens, antiinflammatory agents, nervous system disorders, immunology, psychological disorders | RHONE-POULENC SANTE (FR) | 1992-04-07 | — | — | US | disclosed |